Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    June 2021
  1. PAIK HJ, Jung YJ, Kim DI, Lee S, et al
    Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.
    Oncology. 2021 Jun 7:1-8. doi: 10.1159/000515790.
    >> Share

    March 2021
  2. MONTAGNA G, Tong Y, Ritter M, Levi J, et al
    Predictors of Nodal Pathological Complete Response in Asian Women with Stage II-III Node-Positive Breast Cancer.
    Oncology. 2021 Mar 18:1-6. doi: 10.1159/000513454.
    >> Share

  3. MADEKIVI V, Karlsson A, Bostrom P, Salminen E, et al
    Are Breast Cancer Nomograms Still Valid to Predict the Need for Axillary Dissection?
    Oncology. 2021 Mar 10:1-5. doi: 10.1159/000514616.
    >> Share

  4. ZIMMERMAN BS, Seidman D, Cascetta KP, Ru M, et al
    Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
    Oncology. 2021 Mar 2:1-12. doi: 10.1159/000512212.
    >> Share

    September 2020
  5. BORREANI C, Alfieri S, Infante G, Miceli R, et al
    Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
    Oncology. 2020 Sep 29:1-12. doi: 10.1159/000509651.
    >> Share

    June 2020
  6. CORSO G, Gilardi L, Girardi A, De Scalzi AM, et al
    How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
    Oncology. 2020 Jun 9:1-5. doi: 10.1159/000507707.
    >> Share

    May 2020
  7. DATTACHOUDHURY S, Sharma R, Kumar A, Jaganathan BG, et al
    Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells.
    Oncology. 2020 May 20:1-9. doi: 10.1159/000505521.
    >> Share

    April 2020
  8. HUSZNO J, Kolosza Z, Mrochem-Kwarciak J, Zajusz A, et al
    Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients.
    Oncology. 2020 Apr 28:1-6. doi: 10.1159/000505627.
    >> Share

    March 2020
  9. THARAKAN S, Zimmerman B, Ru M, Blanter J, et al
    Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
    Oncology. 2020 Mar 17:1-4. doi: 10.1159/000506076.
    >> Share

    January 2020
  10. SULEMAN K, Almalik O, Haque E, Mushtaq A, et al
    Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?
    Oncology. 2020 Jan 9:1-6. doi: 10.1159/000504964.
    >> Share

  11. BLANTER J, Zimmerman B, Tharakan S, Ru M, et al
    BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database.
    Oncology. 2020;98:248-251.
    >> Share

    October 2019
  12. FUJITA N, Enomoto Y, Inakami K, Yanagisawa T, et al
    Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.
    Oncology. 2019 Oct 1:1-7. doi: 10.1159/000502910.
    >> Share

    August 2019
  13. GONZALEZ-GONZALEZ L, Gonzalez-Ramirez R, Flores A, Avelino-Cruz JE, et al
    Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.
    Oncology. 2019 Aug 20:1-10. doi: 10.1159/000501802.
    >> Share

  14. ZULAUF N, Bruggmann D, Groneberg D, Oremek GM, et al
    Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
    Oncology. 2019 Aug 14:1-9. doi: 10.1159/000500675.
    >> Share

    July 2019
  15. LEE J, Jeong JH, Jung JH, Kim WW, et al
    Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer.
    Oncology. 2019 Jul 22:1-9. doi: 10.1159/000501340.
    >> Share

    June 2019
  16. KIM JH, Paik HJ, Jung YJ, Kim DI, et al
    A Prospective Longitudinal Study about Change of Sleep, Anxiety, Depression, and Quality of Life in Each Step of Breast Cancer Patients.
    Oncology. 2019 Jun 4:1-9. doi: 10.1159/000500724.
    >> Share

    May 2019
  17. PAGLIARO G, Bernardini F
    A Specific Type of Tibetan Medicine Meditation for Women with Breast Cancer: A Pilot Survey.
    Oncology. 2019 May 15:1-5. doi: 10.1159/000500676.
    >> Share

  18. GUTH U, Elfgen C, Montagna G, Schmid SM, et al
    Long-Term Survival and Cure in Distant Metastatic Breast Cancer.
    Oncology. 2019 May 3:1-12. doi: 10.1159/000500298.
    >> Share

    April 2019
  19. GINZAC A, Passildas J, Gadea E, Abrial C, et al
    Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity.
    Oncology. 2019;96:1-12.
    >> Share

  20. MERY B, Rowinski E, Vallard A, Jacquin JP, et al
    Advocacy for a New Oncology Research Paradigm: The Model of Bevacizumab in Triple-Negative Breast Cancer in a French Cohort Study.
    Oncology. 2019 Apr 2:1-6. doi: 10.1159/000499583.
    >> Share

    March 2019
  21. KOJIMA Y, Yoshie R, Kawamoto H, Shimo A, et al
    Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study.
    Oncology. 2019 Mar 20:1-9. doi: 10.1159/000497276.
    >> Share

    January 2019
  22. EIGELIENE N, Saarenheimo J, Jekunen A
    Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Oncology. 2019 Jan 17:1-10. doi: 10.1159/000495615.
    >> Share

  23. ROININEN N, Takala S, Haapasaari KM, Jukkola-Vuorinen A, et al
    Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
    Oncology. 2019;96:147-155.
    >> Share

    October 2018
  24. THULEAU A, Gilbert C, Bauer P, Alran S, et al
    A New Transcutaneous Method for Breast Cancer Detection with Dogs.
    Oncology. 2018 Oct 2:1-4. doi: 10.1159/000492895.
    >> Share

    September 2018
  25. MUTAI R, Goldvaser H, Shochat T, Peretz I, et al
    Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling.
    Oncology. 2018 Sep 25:1-11. doi: 10.1159/000492429.
    >> Share

    June 2018
  26. BAE SY, Jung SP, Jung ES, Park SM, et al
    Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
    Oncology. 2018 Jun 18:1-7. doi: 10.1159/000488944.
    >> Share

    May 2018
  27. CORSO G, Maisonneuve P, Santomauro GI, De Scalzi AM, et al
    Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients.
    Oncology. 2018 May 30:1-9. doi: 10.1159/000488764.
    >> Share

  28. LANDRY S, Chasles G, Pointreau Y, Bourgeois H, et al
    Influence of an Adapted Physical Activity Program on Self-Esteem and Quality of Life of Breast Cancer Patients after Mastectomy.
    Oncology. 2018 May 30:1-4. doi: 10.1159/000489265.
    >> Share

    January 2018
  29. LEE SJ, Lee J, Kim WW, Jung JH, et al
    Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer.
    Oncology. 2018 Jan 31. pii: 000485658. doi: 10.1159/000485658.
    >> Share

  30. JIA S, Miedel MT, Ngo M, Hessenius R, et al
    Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes.
    Oncology. 2018;94:176-189.
    >> Share

  31. ISHITOBI M, Fukui R, Hashimoto Y, Kittaka N, et al
    pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.
    Oncology. 2018;94:12-18.
    >> Share

  32. GIORDANO G, Febbraro A, Quaquarini E, Turletti A, et al
    Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports.
    Oncology. 2018;94 Suppl 1:34-44.
    >> Share

  33. CATANIA G, Malaguti P, Gasparro S, Cognetti F, et al
    Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
    Oncology. 2018;94 Suppl 1:29-33.
    >> Share

  34. DE SANCTIS R, Agostinetto E, Masci G, Ferraro E, et al
    Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.
    Oncology. 2018;94 Suppl 1:19-28.
    >> Share

  35. NETTUNO R, Menditto C
    Eribulin as a Feasible and Safe Monotherapy in a Dialytic Pretreated Woman with Metastatic Breast Cancer: A Case Report.
    Oncology. 2018;94 Suppl 1:16-18.
    >> Share

  36. PEDERSINI R, Vassalli L, Claps M, Tulla A, et al
    Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study.
    Oncology. 2018;94 Suppl 1:10-15.
    >> Share

  37. MEDICI M, Fossile E
    Long-Term Response with Eribulin Mesylate in a Breast Cancer Patient: A Case Report.
    Oncology. 2018;94 Suppl 1:3-5.
    >> Share

  38. DOTTORINI L, Catena L, Sarno I, Di Menna G, et al
    Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
    Oncology. 2018;94 Suppl 1:6-9.
    >> Share

  39. RESENDE U, Cabello C, Oliveira Botelho Ramalho S, Zeferino LC, et al
    Predictors of Pathological Complete Response in Women with Clinical Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma.
    Oncology. 2018;95:229-238.
    >> Share

    November 2017
  40. KAWAHARA T, Shimozuma K, Shiroiwa T, Hagiwara Y, et al
    Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer.
    Oncology. 2017 Nov 17. doi: 10.1159/000484142.
    >> Share

  41. HOKIMOTO N, Sugimoto T, Namikawa T, Funakoshi T, et al
    A Novel Color Fluorescence Navigation System for Intraoperative Transcutaneous Lymphatic Mapping and Resection of Sentinel Lymph Nodes in Breast Cancer: Comparison with the Combination of Gamma Probe Scanning and Visible Dye Methods.
    Oncology. 2017 Nov 10. doi: 10.1159/000484050.
    >> Share

    September 2017
  42. GAL O, Ishai Y, Sulkes A, Shochat T, et al
    Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome.
    Oncology. 2017 Sep 27. doi: 10.1159/000480087.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016